Acadia Pharmaceuticals
Neil Bair currently serves as Vice President of Access & Reimbursement at Acadia Pharmaceuticals Inc. since March 2022. Prior to this role, Bair was Vice President of Market Access at Biosplice Therapeutics, focusing on first-in-class therapeutics, and held executive positions at Gilead Sciences and Amgen, where responsibilities included developing payer strategies and executing market access plans for key products across various therapeutic areas. Bair's extensive experience also includes roles at Eli Lilly, Northside Cardiology, Methodist Hospitals, and CompuMed Inc., covering marketing, business operations, and account management. Bair holds a Master's degree in Business/Health Care Administration from Indiana University and a Bachelor's degree in Communications/Public Relations from Brigham Young University.
This person is not in the org chart
This person is not in any teams
Acadia Pharmaceuticals
3 followers
Acadia is trailblazing breakthroughs in neuroscience to elevate life. They are at the forefront of healthcare, fighting for breakthroughs in our science, their therapies and the way we work, but also in the lives of the people they serve. Acadia is committed to their purpose: we fight disease so more you shines through.